Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies

Fig. 3

Mean change from baseline on day 16 (safety population) in glucose i-STAT concentration in (a) study A and (b) study B, and mean change from baseline in potassium i-STAT concentration in (c) study A and (d) study B. SD = standard deviation

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us